Trade Summary

1 week ago, Berkowitz Noah, serving as Chief Medical Officer at Arvinas, Inc. (ARVN), sold 5,685 shares at $11.89 per share, for a total transaction value of $67,595.00. Following this transaction, Berkowitz Noah now holds 163,938 shares of ARVN.

This sale represents a 3.00% decrease in Berkowitz Noah's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Friday, February 13, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, February 18, 2026, 5 days after the trade was made.

Arvinas, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.